Hematology CME/CE Courses

Hematology CME/CE Courses

Powered by myCME

Your search for high-quality, complimentary CME/CE stops right here. The courses below are presented by myCME, the continuing education engine in Haymarket Medical Network’s (HMN) expanding portfolio of clinical websites. Below you’ll find practice-relevant courses that carry valuable CME/CE credit. Simply click any link to get started earning credit on myCME.

Featured Courses

Emerging Novel PI3K Inhibitors, Anti-CD20 mAb and Combination Therapy Options for Follicular Lymphoma

Combination Therapy Options for Follicular Lymphoma

Credit: 1.00

TKI Therapy in CML: Emerging Treatments, Ensuring Safety

TKI Therapy in CML

Credit: 1.00

$Emergence of Chemotherapy-Free Regimens for Previously Untreated and Relapsed/Refractory CLL: Highlights from ASCO 2019$

Emerging Targeted-Specific CLL Regimens: ASCO Highlights 2019

Credit: 0.50

Recognizing and Remediating von Willebrand Disease: A Case Study in Collaborative Care

Recognizing and Remediating von Willebrand Disease

Credit: 0.50

Update on Treatment Options for Acute Lymphoblastic Leukemia with An Emphasis on CD19, CD22 Monoclonal Antibodies and Anti-CD19 CAR T-cell Therapy

Update on Treatment Options for Acute Lymphoblastic Leukemia

Credit: 1.50

The Evolution of Multiple Myeloma Patient Management: Managing Today, Preparing for Tomorrow

The Evolution of Multiple Myeloma Patient Management

Credit: 3.00

More Courses

Shaping the Future of Myeloma Treatment

Credit: 0.75

CTCA Forum 2019 Highlights

Credit: 3.25

Suspected VTE Following Radical Prostatectomy

Credit: 1.00

Therapies for Urothelial Carcinoma and Non-Muscle-Invasive Bladder Cancer

Credit: 1.00

Multi-Targeted Tyrosine Kinase Inhibitors and Immunotherapy Options for HCC

Credit: 1.00

Practicing in an Era of Chemo-Free Regimens for R/R CLL

Credit: 1.00

The EGPA Collaborative: Cases of Appropriate Multidisciplinary Management

Credit: 1.00

Preventing and Treating Cancer-Associated VTE

Credit: 0.50

Changing Landscape of Targeted and Immunotherapies for Genitourinary Cancers

Credit: 2.00

Immunotherapy Options for Head & Neck Cancer

Credit: 1.25

Next hm-section-front in CME

General CME/CE Courses